Cary Street Partners Investment Advisory LLC Cyma Bay Therapeutics, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

  • $2.63 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024
BUY
$12.63 - $24.47 $175,557 - $340,133
13,900 New
13,900 $328,000
Q3 2023

Nov 13, 2023
SELL
$10.86 - $17.62 $108,600 - $176,200
-10,000 Reduced 33.33%
20,000 $298,000
Q1 2023

May 12, 2023
SELL
$5.88 - $9.59 $58,800 - $95,900
-10,000 Reduced 25.0%
30,000 $261,000
Q2 2022

Aug 15, 2022
BUY
$1.72 - $3.39 $17,200 - $33,900
10,000 Added 33.33%
40,000 $118,000
Q1 2022

May 16, 2022
BUY
$2.77 - $3.64 $83,100 - $109,200
30,000 New
30,000 $93,000

Others Institutions Holding CBAY

# of Institutions
7
Shares Held
1.82M
Call Options Held
0
Put Options Held
0
View Full List

About CymaBay Therapeutics, Inc.

CBAY Quotes by TradingView
  • Ticker CBAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,677,904
  • Description
  • CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...
More about CBAY
Track This Portfolio

Track Cary Street Partners Investment Advisory LLC Portfolio

Follow Cary Street Partners Investment Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email